Home/Kesmalea Therapeutics/Mark Fox

MF

Mark Fox

Finance Director

Kesmalea Therapeutics

Therapeutic Areas

Oncology Immunology CNS

Kesmalea Therapeutics Pipeline

Drug	Indication	Phase
Undisclosed Oncology Program(s)	Oncology	Preclinical
Undisclosed CNS Program(s)	Central Nervous System Disorders	Preclinical

Leadership Team at Kesmalea Therapeutics

Chief Executive Officer

Chief Scientific Officer & Founder

VP Research & Early Development

View full Kesmalea Therapeutics profile